LY2228820: Advanced p38 MAP Kinase Inhibitor for Anti-Inf...
2026-01-19
LY2228820 is a highly selective p38α/β MAPK inhibitor that empowers researchers with precise modulation of inflammation and tumor progression. This article delivers practical workflows, troubleshooting strategies, and advanced applications for leveraging LY2228820 in apoptosis assays, anti-inflammatory, and angiogenesis inhibition studies—backed by comparative insights and data-driven recommendations.